| 1 |
34076288 | Radiofrequency catheter ablation combined with spironolactone in the treatment of atrial fibrillation: A single-center randomized controlled study. | 2021 Aug |
3 |
| 2 |
34480296 | Repurposing new drug candidates and identifying crucial molecules underlying PCOS Pathogenesis Based On Bioinformatics Analysis. | 2021 Dec |
1 |
| 3 |
31560448 | Effect of Genetic and Nongenetic Factors on the Clinical Response to Mineralocorticoid Receptor Antagonist Therapy in Egyptians with Heart Failure. | 2020 Jan |
3 |
| 4 |
32721806 | Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS). | 2020 Oct |
1 |
| 5 |
31373631 | PKCĪ“ Mediates Mineralocorticoid Receptor Activation by Angiotensin II to Modulate Smooth Muscle Cell Function. | 2019 Sep 1 |
3 |
| 6 |
20592661 | Drug therapy of heart failure: an immunologic view. | 2011 Sep |
1 |
| 7 |
22172779 | A randomized study of the beneficial effects of aldosterone antagonism on LV function, structure, and fibrosis markers in metabolic syndrome. | 2011 Dec |
1 |
| 8 |
18819053 | Contrasting effects of eplerenone and spironolactone on adrenal cell steroidogenesis. | 2009 Jan |
1 |
| 9 |
18347776 | Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles. | 2008 May |
2 |
| 10 |
17995524 | Effects of therapeutic agents on the inflammatory and fibrogenic factors in IgA nephropathy. | 2007 Dec |
1 |
| 11 |
16337046 | Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. | 2006 Jan 26 |
2 |
| 12 |
17043157 | Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism. | 2006 Dec |
3 |
| 13 |
15718497 | Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. | 2005 Apr 1 |
1 |
| 14 |
15749161 | Angiotensin II, angiotensin II antagonists and spironolactone and their modulation of cardiac repolarization. | 2005 Mar |
1 |
| 15 |
16081869 | Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells. | 2005 Sep 2 |
1 |
| 16 |
15159288 | Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. | 2004 Jun 8 |
1 |
| 17 |
15365622 | Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes. | 2004 Oct |
2 |
| 18 |
11836266 | Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humans. | 2002 Feb |
1 |
| 19 |
12427411 | Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy. | 2002 Nov 6 |
2 |
| 20 |
10634408 | Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production. | 2000 Jan |
1 |
| 21 |
10673249 | Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. | 2000 Feb 15 |
2 |
| 22 |
16228919 | The control of adrenergic function in heart failure: therapeutic intervention. | 2000 Mar |
1 |
| 23 |
8422004 | Dose-related cardiovascular effects of spironolactone. | 1993 Jan 21 |
4 |
| 24 |
6086794 | In vitro responses of aldosterone-producing adenomas to angiotensin II and ACTH after treatment with spironolactone before adrenalectomy. | 1984 Aug |
3 |
| 25 |
6385344 | Angiotensin II analogue infusion test in renovascular hypertension under low sodium intake and under spironolactone administration: is angiotensin II analogue infusion test useful in determining the mode of treatment? | 1984 Jul |
2 |
| 26 |
6386025 | Metabolic effects of high dose amiloride and spironolactone: a comparative study in normal subjects. | 1984 Sep |
1 |
| 27 |
973876 | Effect of potassium-sparing diuretics on the renin-angiotensin-aldosterone system and potassium retention in heart failure. | 1976 Oct |
1 |